Schrödinger: Transition Pressure And Competition Offset Ecosystem Strength

Tech and Growth3.61K FollowersFollow5ShareSavePlay(10min)CommentsSummarySchrödinger is rated neutral, with a 1-year price target of $10.6, projecting a -6% YoY decline due to valuation challenges.SDGR’s transition from on-premise to hosted software is depressing near-term revenue growth, creating volatility, and complicating fair valuation.Drug discovery revenue is the key catalyst, with a strong partnership network and a FY 2026 target of $55–$65 million, but competitive risks remain elevated.Improved liquidity and narrowing aEBITDA losses highlight cost discipline, but increased competition and trial uncertainty justify a cautious stance. Hinterhaus Productions/DigitalVision via Getty Images Based in the US, Schrödinger (SDGR) is one of the leading software companies in the scientific and biotechnology verticals, developing a computational platform to accelerate drug discovery and materials science. It mainly makes money throughThis article was written byTech and Growth3.61K FollowersFollowWe're a long-only asset manager allocating into tech and growth asset classes. Learn more at www.tnginvestments.comAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.